Nanalysis Scientific (CVE:NSCI) Stock Price Down 17.2% – Here’s What Happened

Shares of Nanalysis Scientific Corp. (CVE:NSCI) dropped 17.2% during trading on Monday . The company traded as low as C$0.12 and last traded at C$0.12. 148,069 shares were traded during mid-day trading, an increase of 155% from the average session volume of 58,055 shares. The stock had previously closed at C$0.14.

Nanalysis Scientific Stock Up 3.8%

The firm has a 50 day moving average price of C$0.13 and a two-hundred day moving average price of C$0.14. The company has a quick ratio of 1.10, a current ratio of 1.42 and a debt-to-equity ratio of 71.72. The company has a market capitalization of C$18.69 million, a price-to-earnings ratio of -2.70 and a beta of -0.48.

Nanalysis Scientific Company Profile

Nanalysis Scientific Corp. engages in the development, manufacture, and sale of magnetic resonance products in the United States, Canada, Europe, Asia, and internationally. The company operates through four segments: Nanalysis, RS2D, K'Prime, and Corporate. It offers nuclear magnetic resonance (NMR) spectrometers; software module packages; cutting-edge electronics components for precision analytical instruments; and services for its NMR technologies. It serves pharmaceutical, security, biotech, nutraceutical, chemical, food, materials, medical, and education industries.